Emerald Clinical Trials India Private Limited, a active foreign private limited company, was established on 04 October 2012 in Bangalore North, Karnataka, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100KA2012FTC080639. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 103 professional, Its leadership includes Mamatha Thankam Jacob (Director), Ghosh Dwaipayan (Director), Anthony Stephen Proctor (Director). Past directors included Vinodvenkatesh Ramachandragouda Patil, Ganesh Pai Panduranga, Cheong Kok Hwee. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Municipal No-5, 12Th Floor Prestige Khoday Towers,, Raj Bhavan Road, Bangalore North, Karnataka, 560001.
U73100KA2012FTC080639
080639
04 October 2012
₹0.50 M
₹0.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Emerald Clinical Trials India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mamatha Thankam Jacob | Director | 26 Sep 2024 | Current |
| Ghosh Dwaipayan | Director | 12 Jun 2025 | Current |
| Anthony Stephen Proctor | Director | 08 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jun 2013 | Past |
| Pramod Abcsdd | Director | 31 Jul 2021 | Past |
| Pramod Abcsdd | Additional Director | 27 Aug 2019 | Past |
| Pramod Abcsdd | Managing Director | 26 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 15 Sep 2020 | Past |
| Pramod Abcsdd | Director | 01 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
George Clinical India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 71.5% increase. The company also saw a substantial improvement in profitability, with a 114.64% increase in profit. The company's net worth Soared by an impressive increase of 75.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Emerald Clinical Trials India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Emerald Clinical Trials India has a workforce of 103 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Emerald Clinical Trials India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emerald Clinical Trials India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Anthony Stephen Proctor was appointed as a Director was appointed as a Director on 08 Oct 2025 & has been associated with this company since 2 months 20 days . was completed.
The activity Ghosh Dwaipayan was appointed as a Director was appointed as a Director on 12 Jun 2025 & has been associated with this company since 6 months 16 days . was completed.
Progress on Mamatha Thankam Jacob was appointed as a Director was appointed as a Director on 26 Sep 2024 & has been associated with this company since 1 year 3 months . was documented.
Progress on Emerald Clinical Trials India Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was documented.
Progress on Emerald Clinical Trials India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Emerald Clinical Trials India Private Limited was registered on 04 Oct 2012 with Roc Bangalore & aged 13 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Emerald Clinical Trials India Private Limited is U73100KA2012FTC080639.
Emerald Clinical Trials India Private Limited is headquartered at Municipal No-5, 12Th Floor Prestige Khoday Towers,, Raj Bhavan Road, Bangalore North, Karnataka, 560001.
Emerald Clinical Trials India Private Limited was incorporated on 04 October 2012.
The current directors of Emerald Clinical Trials India Private Limited are
The primary industry of Emerald Clinical Trials India Private Limited is Professional, Scientific And Technical.
Emerald Clinical Trials India Private Limited is unlisted.
The authorized capital of Emerald Clinical Trials India Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Emerald Clinical Trials India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX